Indications
- Surplus embryos which can be used for the same patient at a later date
- Danger of ovarian hyperstimulation syndrome where the cycle is cancelled
- Patient takes ill after oocyte aspiration
- Donor oocyte programmes
- When the progesterone level is high (=1 ng/ml) at the time of HCG injection.
- When the implantation site is not favorable either due to a poor endometrial reaction or presence of polyps.
The most important criterion in cryopreservation is that the cell must maintain the structural integrity throughout the cryopreservation procedure. The whole aim is to reduce damage caused by intra–cellular ice formation. This can be achieved by dehydrating the cell before or during cooling procedure, failing which the large intra-cellular crystals can damage the cells.
There are two methods of cryopreservation
- Rapid cooling / vitrification
- Slow cooling
Rapid cooling protocol involves media containing higher concentration of cryoprotectants and has a relatively much shorter freezing time. It is said to be beneficial especially for freezing oocytes. Please see our research link.
Slow cooling involves seeding where the cryopreservation straw is manually touched by a cold forceps dipped in liquid nitrogen further away from the embryo to initiate ice formation which gradually spreads to the rest of the solution containing the embryos. This prevents the damage to the embryos. This process utilizes lesser concentration of cryoprotectants and is of longer duration.
Thawing
During this procedure the frozen sperm/oocytes/embryos/blastocysts are thawed to room temperature, observed for further development and then transferred into the patient’s uterus either in a natural cycle or following hormone replacement. At the time of embryo replacement, the straws are removed from the liquid nitrogen and placed in a water bath at room temperature before re-hydrating with special media. At the end of re-hydration, the embryos are cultured in media within the carbon dioxide incubators and allowed to develop further either to day 2 or blastocyst prior to transfer.
|